Two needle-free COVID-19 vaccines are now available — to some people at least. India has approved a squirt-in-the-nose option and China has cleared an oral version that you inhale through the mouth. They could be a game-changer in terms of vaccine access. Marco Werman speaks with Scripps Research executive vice president Eric Topol about how the new vaccines work and what their impact could be on combating the virus.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?